Development of a marker-free mutagenesis system using CRISPR-Cas9 in the pathogenic mould Aspergillus fumigatus. (2020)
Attributed to:
From Bug to Drug: A laboratory to pharma discovery loop for direct sourcing of antifungal peptide aptamers
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.fgb.2020.103479
PubMed Identifier: 33122116
Publication URI: http://europepmc.org/abstract/MED/33122116
Type: Journal Article/Review
Volume: 145
Parent Publication: Fungal genetics and biology : FG & B
ISSN: 1087-1845